Adhesion molecules, mycophenolate mofetil and systemic lupus erythematosus

Area of Science:

• Immunology
• Cell Biology
• Pharmacology

Background:

• Mycophenolate mofetil (MMF) is known to inhibit lymphocyte adhesion and endothelial cell penetration.
• The exact mechanism of MMF's action on these processes remains unclear.
• Conflicting in vitro data exist regarding MMF's effect on endothelial cell adhesion molecules (CAMs).

Purpose of the Study:

• To review and analyze the literature on MMF's effects on cell adhesion molecules (CAMs).
• To explore the potential mechanisms by which MMF influences lymphocyte-endothelial cell interactions.
• To discuss the relevance of CAMs in systemic lupus erythematosus (SLE) in the context of MMF therapy.

Main Methods:

• Literature review of in vitro and in vivo studies on MMF and CAMs.
• Analysis of studies investigating MMF's impact on ICAM-1, VCAM-1, and E-selectin expression and function.
• Examination of research on MMF's effects on lymphocyte CAM glycosylation and binding capabilities.

Main Results:

• In vitro studies show inconsistent effects of MMF on ICAM-1 and VCAM-1 expression.
• Evidence suggests MMF may reduce endothelial E-selectin expression.
• Recent findings indicate MMF alters lymphocyte CAM binding ability rather than surface expression.

Conclusions:

• The precise mechanism of MMF's immunosuppressive action via CAM modulation requires further investigation.
• Key ligand pairs like ICAM-1/LFA-1, VCAM-1/VLA-4, and P-selectin/PSGL-1 are implicated.
• More in vivo and conclusive human studies are needed to fully understand MMF's role in conditions like SLE.